Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Clinical trial NCT03674411 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03674411
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2020-06-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.